ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-21V14257
Home | Market Reports | Health| Health Foundations & Medical Research
Global Adipose Tissue derived Stem Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2025

Code: QYRE-Auto-21V14257
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem Inc
Cytori Therapeutics
Intrexon
Mesoblast Limited
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Cyagen
Lonza
Pluristem Therapeutics

Adipose Tissue-derived Stem Cell Therapy Market

The global market for Adipose Tissue-derived Stem Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.
North American market for Adipose Tissue-derived Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Adipose Tissue-derived Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Adipose Tissue-derived Stem Cell Therapy include AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast, Pluristem Therapeutics, Tissue Genesis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adipose Tissue-derived Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Tissue-derived Stem Cell Therapy.
The Adipose Tissue-derived Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adipose Tissue-derived Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adipose Tissue-derived Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Adipose Tissue-derived Stem Cell Therapy Market Report

Report Metric Details
Report Name Adipose Tissue-derived Stem Cell Therapy Market
Segment by Type
  • Autologous Stem Cells
  • Allogeneic Stem Cells
Segment by Application
  • Therapeutic Application
  • Research Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast, Pluristem Therapeutics, Tissue Genesis, BioRestorative Therapies, Celltex Therapeutics Corporation, iXCells Biotechnologies, Cyagen, Lonza
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adipose Tissue-derived Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adipose Tissue-derived Stem Cell Therapy Market report?

Ans: The main players in the Adipose Tissue-derived Stem Cell Therapy Market are AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast, Pluristem Therapeutics, Tissue Genesis, BioRestorative Therapies, Celltex Therapeutics Corporation, iXCells Biotechnologies, Cyagen, Lonza

What are the Application segmentation covered in the Adipose Tissue-derived Stem Cell Therapy Market report?

Ans: The Applications covered in the Adipose Tissue-derived Stem Cell Therapy Market report are Therapeutic Application, Research Application

What are the Type segmentation covered in the Adipose Tissue-derived Stem Cell Therapy Market report?

Ans: The Types covered in the Adipose Tissue-derived Stem Cell Therapy Market report are Autologous Stem Cells, Allogeneic Stem Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous Stem Cells
1.2.3 Allogeneic Stem Cells
1.3 Market by Application
1.3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Therapeutic Application
1.3.3 Research Application
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Adipose Tissue-derived Stem Cell Therapy Growth Trends by Region
2.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Adipose Tissue-derived Stem Cell Therapy Market Dynamics
2.3.1 Adipose Tissue-derived Stem Cell Therapy Industry Trends
2.3.2 Adipose Tissue-derived Stem Cell Therapy Market Drivers
2.3.3 Adipose Tissue-derived Stem Cell Therapy Market Challenges
2.3.4 Adipose Tissue-derived Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue
3.1.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adipose Tissue-derived Stem Cell Therapy Revenue
3.4 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adipose Tissue-derived Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Adipose Tissue-derived Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Adipose Tissue-derived Stem Cell Therapy, Product and Application
3.7 Global Key Players of Adipose Tissue-derived Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Type
4.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Application
5.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size (2020-2031)
6.2 North America Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AlloCure
11.1.1 AlloCure Company Details
11.1.2 AlloCure Business Overview
11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Introduction
11.1.4 AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.1.5 AlloCure Recent Development
11.2 Antria
11.2.1 Antria Company Details
11.2.2 Antria Business Overview
11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Introduction
11.2.4 Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.2.5 Antria Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.3.4 Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.3.5 Celgene Corporation Recent Development
11.4 Cellleris
11.4.1 Cellleris Company Details
11.4.2 Cellleris Business Overview
11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Introduction
11.4.4 Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.4.5 Cellleris Recent Development
11.5 Corestem
11.5.1 Corestem Company Details
11.5.2 Corestem Business Overview
11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Introduction
11.5.4 Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.5.5 Corestem Recent Development
11.6 Cytori Therapeutics
11.6.1 Cytori Therapeutics Company Details
11.6.2 Cytori Therapeutics Business Overview
11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.6.4 Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.6.5 Cytori Therapeutics Recent Development
11.7 Intrexon
11.7.1 Intrexon Company Details
11.7.2 Intrexon Business Overview
11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Introduction
11.7.4 Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.7.5 Intrexon Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Details
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Details
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.9.5 Pluristem Therapeutics Recent Development
11.10 Tissue Genesis
11.10.1 Tissue Genesis Company Details
11.10.2 Tissue Genesis Business Overview
11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Introduction
11.10.4 Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.10.5 Tissue Genesis Recent Development
11.11 BioRestorative Therapies
11.11.1 BioRestorative Therapies Company Details
11.11.2 BioRestorative Therapies Business Overview
11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Introduction
11.11.4 BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.11.5 BioRestorative Therapies Recent Development
11.12 Celltex Therapeutics Corporation
11.12.1 Celltex Therapeutics Corporation Company Details
11.12.2 Celltex Therapeutics Corporation Business Overview
11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.12.4 Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.12.5 Celltex Therapeutics Corporation Recent Development
11.13 iXCells Biotechnologies
11.13.1 iXCells Biotechnologies Company Details
11.13.2 iXCells Biotechnologies Business Overview
11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Introduction
11.13.4 iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.13.5 iXCells Biotechnologies Recent Development
11.14 Pluristem Therapeutics
11.14.1 Pluristem Therapeutics Company Details
11.14.2 Pluristem Therapeutics Business Overview
11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.14.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.14.5 Pluristem Therapeutics Recent Development
11.15 Cyagen
11.15.1 Cyagen Company Details
11.15.2 Cyagen Business Overview
11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Introduction
11.15.4 Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.15.5 Cyagen Recent Development
11.16 Lonza
11.16.1 Lonza Company Details
11.16.2 Lonza Business Overview
11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Introduction
11.16.4 Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
11.16.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem Inc
Cytori Therapeutics
Intrexon
Mesoblast Limited
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Cyagen
Lonza
Pluristem Therapeutics
List of Tables
 Table 1. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Autologous Stem Cells
 Table 3. Key Players of Allogeneic Stem Cells
 Table 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2020-2025)
 Table 8. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2026-2031)
 Table 10. Adipose Tissue-derived Stem Cell Therapy Market Trends
 Table 11. Adipose Tissue-derived Stem Cell Therapy Market Drivers
 Table 12. Adipose Tissue-derived Stem Cell Therapy Market Challenges
 Table 13. Adipose Tissue-derived Stem Cell Therapy Market Restraints
 Table 14. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2024)
 Table 17. Ranking of Global Top Adipose Tissue-derived Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Adipose Tissue-derived Stem Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Adipose Tissue-derived Stem Cell Therapy, Product and Application
 Table 21. Global Key Players of Adipose Tissue-derived Stem Cell Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AlloCure Company Details
 Table 47. AlloCure Business Overview
 Table 48. AlloCure Adipose Tissue-derived Stem Cell Therapy Product
 Table 49. AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 50. AlloCure Recent Development
 Table 51. Antria Company Details
 Table 52. Antria Business Overview
 Table 53. Antria Adipose Tissue-derived Stem Cell Therapy Product
 Table 54. Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 55. Antria Recent Development
 Table 56. Celgene Corporation Company Details
 Table 57. Celgene Corporation Business Overview
 Table 58. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product
 Table 59. Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 60. Celgene Corporation Recent Development
 Table 61. Cellleris Company Details
 Table 62. Cellleris Business Overview
 Table 63. Cellleris Adipose Tissue-derived Stem Cell Therapy Product
 Table 64. Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 65. Cellleris Recent Development
 Table 66. Corestem Company Details
 Table 67. Corestem Business Overview
 Table 68. Corestem Adipose Tissue-derived Stem Cell Therapy Product
 Table 69. Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 70. Corestem Recent Development
 Table 71. Cytori Therapeutics Company Details
 Table 72. Cytori Therapeutics Business Overview
 Table 73. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
 Table 74. Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 75. Cytori Therapeutics Recent Development
 Table 76. Intrexon Company Details
 Table 77. Intrexon Business Overview
 Table 78. Intrexon Adipose Tissue-derived Stem Cell Therapy Product
 Table 79. Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 80. Intrexon Recent Development
 Table 81. Mesoblast Company Details
 Table 82. Mesoblast Business Overview
 Table 83. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product
 Table 84. Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 85. Mesoblast Recent Development
 Table 86. Pluristem Therapeutics Company Details
 Table 87. Pluristem Therapeutics Business Overview
 Table 88. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
 Table 89. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 90. Pluristem Therapeutics Recent Development
 Table 91. Tissue Genesis Company Details
 Table 92. Tissue Genesis Business Overview
 Table 93. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product
 Table 94. Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 95. Tissue Genesis Recent Development
 Table 96. BioRestorative Therapies Company Details
 Table 97. BioRestorative Therapies Business Overview
 Table 98. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product
 Table 99. BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 100. BioRestorative Therapies Recent Development
 Table 101. Celltex Therapeutics Corporation Company Details
 Table 102. Celltex Therapeutics Corporation Business Overview
 Table 103. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product
 Table 104. Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 105. Celltex Therapeutics Corporation Recent Development
 Table 106. iXCells Biotechnologies Company Details
 Table 107. iXCells Biotechnologies Business Overview
 Table 108. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product
 Table 109. iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 110. iXCells Biotechnologies Recent Development
 Table 111. Pluristem Therapeutics Company Details
 Table 112. Pluristem Therapeutics Business Overview
 Table 113. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
 Table 114. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 115. Pluristem Therapeutics Recent Development
 Table 116. Cyagen Company Details
 Table 117. Cyagen Business Overview
 Table 118. Cyagen Adipose Tissue-derived Stem Cell Therapy Product
 Table 119. Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 120. Cyagen Recent Development
 Table 121. Lonza Company Details
 Table 122. Lonza Business Overview
 Table 123. Lonza Adipose Tissue-derived Stem Cell Therapy Product
 Table 124. Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 125. Lonza Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Adipose Tissue-derived Stem Cell Therapy Picture
 Figure 2. Global Adipose Tissue-derived Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Autologous Stem Cells Features
 Figure 5. Allogeneic Stem Cells Features
 Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Therapeutic Application Case Studies
 Figure 9. Research Application Case Studies
 Figure 10. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
 Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 14. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players in 2024
 Figure 15. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2024
 Figure 17. North America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 19. United States Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 23. Germany Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2020-2031)
 Figure 31. China Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 39. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 43. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. AlloCure Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 47. Antria Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 48. Celgene Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 49. Cellleris Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 50. Corestem Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 51. Cytori Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 52. Intrexon Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 53. Mesoblast Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 54. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 55. Tissue Genesis Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 56. BioRestorative Therapies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 57. Celltex Therapeutics Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 58. iXCells Biotechnologies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 59. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 60. Cyagen Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 61. Lonza Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Adipose Derived Stem Cell Therapy Market Research Report 2024
Adipose Tissue Derived Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adipose Derived Stem Cell Storage Service Market Research Report 2024
Global Mesenchymal Stem Cell Drugs Market Research Report 2024
Global Stem Cell Therapy Market Insights Forecast to 2030
Mesenchymal Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adipose Stem Cells and Adipose Tissue Cryopreservation Solution Market Research Report 2025
Global Mesenchymal Stem Cell Injection Market Research Report 2024
Global Stem Cell Services Market Insights Forecast to 2030
Global Cardiology Stem Cells Market Research Report 2024
Global Human Mesenchymal Stem Cells hMSC Market Insights Forecast to 2030
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Advanced Cell Therapies Market Research Report 2024
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2024
Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Therapy for Infertility Market Research Report 2024
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Global Osteoarthritis Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions